2m 2m 2m 2m 2m 2m 2m
Kura Oncology (KURA)
NASDAQ
$11.12+$0.21 (+1.96%)
Price as of Jul 13, 2026 7:28 PM EDT- $1.0BMarket Cap
- 71.81%1-Year Change
- BiotechnologyIndustry
Kura Oncology (KURA)
$11.12+$0.21 (+1.96%)
KURA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.91 | ||
Change | -$0.54 (-4.72%) | ||
Open | $11.16 | ||
High | $11.33 | ||
Low | $10.86 | ||
Previous Close | $11.45 | ||
Volume | 1,579,693 | ||
30-Day Average Volume | 1,835,338 | ||
1-Week Change | -1.18% | ||
1-Month Change | 20.55% | ||
1-Year Change | 71.81% | ||
3-Year Change | 8.77% | ||
5-Year Change | -42.06% | ||
Fundamentals | |||
Shares Outstanding | 88.8M | ||
Total Assets | $652.6M | ||
Market Cap | $1.0B | ||
Enterprise Value | $987.1M | ||
Period: QTR TTM FY | |||
Revenue | $5.8M | ||
Net Income | -$73.3M | ||
Free Cash Flow | -$86.0M | ||
EBIT | -$73.3M | ||
EBITDA | -$73.0M | ||
Net Working Capital | $522.3M | ||
EPS | -$0.83 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | 171 | ||
P/B | 9 | ||
P/E | -14 | ||
PEG | -1 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue